Galantamine inhibits β‐amyloid‐induced cytostatic autophagy in PC12 cells through decreasing ROS production

OBJECTIVES: Alzheimer's disease (AD) is one of the most prevalent brain diseases among the elderly, majority of which is caused by abnormal deposition of amyloid beta‐peptide (Aβ). Galantamine, currently the first‐line drug in treatment of AD, has been shown to diminish Aβ‐induced neurotoxicity...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cell Prolif
Главные авторы: Jiang, Sheng, Zhao, Ye, Zhang, Tao, Lan, Jingbin, Yang, Jing, Yuan, Longhui, Zhang, Qiyu, Pan, Kejian, Zhang, Kun
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2018
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6528845/
https://ncbi.nlm.nih.gov/pubmed/29292543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12427
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы